Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: A survey of centres participating in a national randomised controlled trial

Oral Oncology

Volumn 50, Issue 2, 2014, Pages 141-146

  Gujral, D M ^a   Piercy, D ^b   Morden, J P ^b   Emson, M ^b   Hall, E ^b   Miah, A B ^a   Bhide, S A ^a   Newbold, K L ^a   Harrington, K J ^a,b   Nutting, C M ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Advanced; Chemoradiation; Chemotherapy; Head and neck cancer; Induction

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL PRACTICE; HEAD AND NECK CANCER; HEALTH SURVEY; HUMAN; HYPOPHARYNX CANCER; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; LARYNX CANCER; LYMPH NODE METASTASIS; MULTICENTER STUDY (TOPIC); MULTIPLE CYCLE TREATMENT; ONCOLOGIST; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED KINGDOM;

ADVANCED; CHEMORADIATION; CHEMOTHERAPY; HEAD-AND-NECK CANCER; INDUCTION;

ATTITUDE OF HEALTH PERSONNEL; GREAT BRITAIN; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INDUCTION CHEMOTHERAPY; LARYNGEAL NEOPLASMS; MEDICAL ONCOLOGY;

EID: 84891830351     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.10.012     Document Type: Article

References (29)

1. A. Eisbruch Commentary: induction chemotherapy for head and neck cancer: hypothesis-based rather than evidence-based medicine Oncologist 12 2007 975 977
2. D.J. Adelstein Redefining the role of induction chemotherapy in head and neck cancer J Clin Oncol 26 2008 3117 3119
3. J.J. Beitler, and J.S. Cooper Seduction by induction? J Clin Oncol 27 2009 9 10
4. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
5. A. Paccagnella et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo J Natl Cancer Inst 86 1994 265 272
6. D.E. Schuller, B. Metch, D.W. Stein, D. Mattox, and J.D. McCracken Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group Laryngoscope 98 1988 1205 1211
7. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90.
8. F.P. Worden et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number J Clin Oncol 26 2008 3138 3146
9. R. Hitt et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer J Clin Oncol 23 2005 8636 8645
10. J.B. Vermorken et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
11. M.R. Posner et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
12. http://www.controlled-trials.com/ISRCTN01483375/art-deco.
13. L. Sobin, M. Gospodarowicz, and C. Wittekind UICC (International Union against cancer) TNM classification of malignant tumours 7th ed. 2010 Blackwell Oxford p.30-45
14. R. Stupp, R.R. Weichselbaum, and E.E. Vokes Combined modality therapy of head and neck cancer Semin Oncol 21 1994 349 358
15. J.P. Pignon, J. Bourhis, C. Domenge, and L. Designe Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer Lancet 355 2000 949 955
16. C. Monnerat, S. Faivre, S. Temam, J. Bourhis, and E. Raymond End points for new agents in induction chemotherapy for locally advanced head and neck cancers Ann Oncol 13 2002 995 1006
17. A.A. Forastiere et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer J Clin Oncol 31 2013 845 852
18. J.L. Lefebvre et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
19. Y. Pointreau et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
20. D.M. Brizel, and E.E. Vokes Induction chemotherapy: to use or not to use? That is the question Semin Radiat Oncol 19 2009 11 16
21. J.P. Pignon et al. Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck Anticancer Drugs 15 2004 331 340
22. C.M. Nutting, S.A. Bhide, and K.J. Harrington Treatment of head and neck cancer N Engl J Med 358 2008 1076 1077 [author reply 1077-8]
23. H. Qin et al. Combination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis PLoS One 7 2012 e51526
24. P. Blanchard et al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group J Clin Oncol 31 2013 2854 2860
25. R. Haddad et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial Lancet Oncol 14 2013 257 264
26. A.C. Wilkins et al. Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis Oral Oncol 2013
27. K.T. Cohen EEW, M. Kocherginsky, C.H. Huang, M. Agulnik, B.B. Mittal, and F. Yunus et al. DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin, 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN) J Clin Oncol 2012 30 Abstract 5500
28. J.L. Lefebvre et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study J Clin Oncol 31 2013 853 859
29. M. Rooney et al. Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120 h 5-FU infusion and cisplatin Cancer 55 1985 1123 1128